High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia - Archive ouverte HAL Access content directly
Journal Articles Leukemia Research Year : 2010

High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia

(1) , (1) , (1) , (2) , (1) , (3)
1
2
3

Abstract

Increased BMI has been correlated to an increased incidence of APL, but not to the occurrence of differentiation syndrome (DS) in APL. We consecutively treated 39 APL patients with ATRA and idarubicin ( according to PETHEMA regimen). Median age was 26 years. Forty-one percent patients were classified as intermediate risk, and 59% as high risk according to Sanz's score. Thirty-three patients (85%) reached CR. Eleven of the 36 patients evaluable for DS (30.5%) developed this syndrome (severe in 7 cases, moderate in 4, and fatal in 3 cases) within a median of 12 days (range 3-23) of ATRA onset. Six of the 9 (66.6%) patients with BMI >= 30 developed DS vs. 5 of 27 (18.5%) with BMI<30 (p = 0.012). Other predictors of DS in univariate analysis were: age >= 40 year (p = 0.033), baseline WBC >= 20 x 10(9)/l (p = 0.003), and creatinine > 1.4 mg/dl (p = 0.009). In multivariate analysis, BMI >= 30 remained an independent predictor of DS in addition to baseline WBC >= 20 x 10(9)/l. (C) 2009 Elsevier Ltd. All rights reserved.
Not file

Dates and versions

pasteur-01375286 , version 1 (21-12-2016)

Identifiers

Cite

Ramzi Jeddi, Héla Ghédira, Balkis Meddeb, Samia Mnif, Emna Gouider, et al.. High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia. Leukemia Research, 2010, 34 (4), pp.545-547. ⟨10.1016/j.leukres.2009.09.017⟩. ⟨pasteur-01375286⟩
39 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More